Profil
Mr. Tom Burnett is Director & President-Medical Isotopes at Nordion (Canada), Inc. and President & Director at LPBP, Inc. He is on the Board of Directors at Nordion (Canada), Inc. and LPBP, Inc. He received his undergraduate degree from the University of Western Ontario, a graduate degree from Queen's University and an MBA from Richard Ivey School of Business.
Postes actifs de Tom Burnett
| Sociétés | Poste | Début |
|---|---|---|
| NORDION INC | Director/Board Member | 01/01/2006 |
| LPBP INC | Chairman | - |
Formation de Tom Burnett
| Queen's University | Graduate Degree |
| University of Western Ontario | Undergraduate Degree |
| Richard Ivey School of Business | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Nordion (Canada), Inc.
 Nordion (Canada), Inc. Pharmaceuticals: MajorHealth Technology Nordion (Canada), Inc. provides drug discovery and development research services. It specializes in health science, gamma irradiation, radiopharmaceutical, gamma sterilization, medical isotopes, and production irradiators. The company was founded in 1946 and is headquartered in Ottawa, Canada. | Health Technology |
LPBP, Inc.
 LPBP, Inc. Financial ConglomeratesFinance LPBP, Inc. is a development stage company. It was previously engaged in blood products business and clinical laboratories services. The company was founded on July 11, 1985 and is headquartered in Ottawa, Canada. | Finance |
